Selected Abstracts from the February Issue of the Journal of Vascular Surgery  by unknown
Eur J Vasc Endovasc Surg (2009) 37, 246e248Selected Abstracts from the February Issue of the Journal of Vascular Surgery*Feasibility of simultaneous pre- and postfilter transcranial Doppler
monitoring during carotid artery stenting
Zsolt F. Garami, Jean Bismuth, Kristofer M. Charlton-Ouw, Mark G. Davies,
Eric K. Peden, Alan B. Lumsden
Objective: Carotid artery stenting (CAS) is emerging as an acceptable treat-
ment alternative to surgery for patientswith carotid artery stenosis. Themajor
risk of CAS is cerebral embolization of plaque and thrombus causing stroke or
asymptomatic brain infarction. Use of embolic protection devices (EPD) to trap
emboli before they reach the brain is now standard practice in CAS. The pore
size of the currently available filters is >100 microns and emboli smaller than
theEPDporescan still reach thebrain.While theuseof EPD iswidespread, little
evidence exists of their in vivo efficacy in preventing distal embolization. Our
aim was to quantify the number of emboli reaching the brain with the device
in place. Therefore, the expected value of this report is in its description of
a novel application of transcranial Doppler (TCD). Due to the limited number
of cases, it is not intended to support the use of one EPD over another.
Methods: Six patients were monitored with ipsilateral simultaneous dual
probe TCD during CAS. Two types of cerebral protection systems were eval-
uated: FilterWire EZ System (FW; Boston Scientific, Santa Clara, Calif) and
GORE Neuro Protection System (NPS; W.L. Gore and Associates, Flagstaff,
Ariz). By placing TCD probes both proximal and distal to the filterwire
EPD, we quantified the microembolic signals before the EPD as well as those,
which reached the intracranial circulation after the EPD. One probe was
placed submandibularly to monitor the ICA (SICA), while another was placed
transtemporally to monitor the middle and anterior cerebral artery (MCA þ
ACA). We compare the number of extracranial emboli prior to the EPD with
the number of intracranial emboli after the EPD.
Results: Dual probe monitoring was successful during the five stages of the
CAS: lesion crossing (LC), predilatation (PreD), stent placement (SP), postdi-
latation (PostD), and filter/device removal (FR/DR). Using FW during LC by
probe 1 (SICA)/probe 2 (MCA þ ACA): (18 [range 15-22]/15 [range 11-20] ),
PreD (111 [range 101-121]/101 [range 90-111] ), SP (68 [range 60-76]/42
[range 30-53] ), PostD (27 [range 25-30]/24 [range 22-27]), FR (0.3 [range
0-1]/0.7 [range 0-1]) average number of microembolic signals were de-
tected. Using NPS during LC (1.7 [range 0-3]/1 [range 0-2]), PreD (0/1.7
[range 0-4]), SP (0/0), PostD (0/0), DR (18 [range 0-18]/6.7 [range 1-13])
average number of microembolic signals were detected.
Conclusion: EPD significantly reduces but does not eliminate the number ofmi-
croemboli reaching thebrain during carotid artery angioplasty and stenting.We
propose monitor of CAS with submandibular and transtemporal TCD probes to
further evaluate the practice of distal embolization protection. Although our
study isnotpowered tomakeany recommendationsaboutEPDs,webelieve that
sequential dual probeTCDmonitoring is a worthy tool with the potential to give
vital information to assess the various devices and the techniques of utilization.Cryo stripping versus conventional stripping of the great saphenous vein:
A multicenter randomized clinical trial of efficacy
Taco M.A.L. Klem, J. Marco Schnater, P. Ronald Schu¨tte, Wim Hop, Arie C.
van der Ham, Cornelis H.A. Wittens
Objective: This multicenter randomized clinical trial compared cryo strip-
ping of the great saphenous vein (GSV) with conventional stripping.* Full articles available online at www.jvascsurg.org
1078e5884/$34.00
doi:10.1016/S1078-5884(08)00679-5Methods: The study randomized 494 patients with symptomatic (CEAP) clin-
ical severity class 2 to 4 to cryo stripping (n = 249) or conventional stripping
(n = 245). The primary outcome was residual GSV 6 months after surgery
measured by venous duplex ultrasound imaging. Secondary outcomes were
quality of life, operation time, and postoperative neural damage. Duration
of follow-up was 6 months. Quality of life was measured at 6 and 26 weeks
postoperatively with the Aberdeen Varicose Vein Questionnaire (AVVQ) and
Medical Outcomes Study Short-Form 36 (SF-36) Health Survey.
Results: The two groups were well matched at baseline. The percentage of
patients with residual GSV at 6 months (primary outcome) was 44% (102 of
230) in the cryo group and 15% (33 of 215) in the conventional group (differ-
ence 29%; 95% confidence interval [CI], 21%-37%, P < .001). Median operation
time was significantly shorter in the cryo group (30 minutes) compared with
the conventional group (39 minutes). Neural damage was 12% in both groups,
and thus not significantly different. Scores on the subdomains of the SF-36
showed no significant change between the groups. The AVVQ after conven-
tional stripping was 8.0, which was a better result than the 11.7 result after
cryo stripping (difference 2.6 points; 95% CI, 1.0-4.2; P = .001, repeated
measurements analysis of variance with adjustment for baseline scores).
Conclusion: Cryo stripping accounts for numerous procedural failures and
hence residual GSV in patients. The AVVQ showed small but significantly
better results for patients after a conventional stripping. Cryo stripping
has no benefits over conventional stripping.Chronic kidney disease classification stratifies mortality risk after elective
stent-graft repair of the thoracic aorta
Massimiliano M. Marrocco-Trischitta, Germano Melissano, Andrea Kahlberg,
Giliola Calori, Francesco Setacci, Roberto Chiesa
Objective: Risk factors for perioperative and late mortality after thoracic
endovascular aortic repair (TEVAR) remain ill-defined. In this study, we
examined the prognostic significance of chronic kidney disease (CKD),
a well-known predictor of death after thoracic aorta open repair, employing
a stratification based on CKD stages derived from glomerular filtration rate
(GFR) values.
Methods: A prospective database was evaluated for 179 consecutive
patients electively submitted to TEVAR between 1999 and 2007. Preopera-
tive GFR was estimated by using the Cockcroft-Gault equation. Patient
groups were stratified into four quartiles by baseline serum creatinine (SC)
and GFR values, with quartile I being the lowest, and quartile IV the highest,
and into the five CKD stages in reverse order (I GFR  90 ml/min/1.73 m2; II
60-89; III 30-59; IV 15-29; V < 15). Prognostic significance of preoperative
GFR values and CKD stages were investigated by means of univariate and
multivariate analyses, and the Kaplan-Meier log-rank method.
Results: A primary technical success was achieved in 166 of 179 patients
(92.7%), and an initial clinical success in 158 (88.3%). Thirty-day mortality
was 5% (nine cases). Paraplegia or paraparesis were observed in 11 (6.1%)
patients, and completely resolved in six cases after cerebrospinal fluid
drainage. Preoperative GFR quartiles and CKD stages were significant predic-
tors of 30-day mortality (P = .004 and P < .0001 respectively), whereas SC
quartiles did not affect the outcome (P = .12). In particular, GFR quartile I
(<60 ml/min/1.73 m2) was associated with a ten-fold greater risk of perio-
perative death compared with the other three quartiles (Odds Ratio 11.4,
95% Confidence Interval 2.3-57.0, P = .003). Midterm survival was 88.8%
(159 of 179) at a mean follow-up of 35.6  23.7 months. Actuarial survival
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respectively (P < .0001), and 0.0%, 66.7%, 59.2%, 88.6%, and 100%
(P < .0001) for CKD stage V to I respectively. At univariate analyses, age
(P = .019), preoperative SC quartiles (P = .001), GFR quartiles (P = .0002),
and CKD stages (P < .0001) were all predictive of mid-term mortality. At
multivariate Cox proportional hazards regression analysis, only CKD stages
remained independently associated with the outcome (P = .008).
Conclusion: GFR is an accurate prognostic predictor in patients submitted to
TEVAR. Also, perioperative and midterm mortality directly correlate with
the severity of CKD stages, allowing a risk stratification model to be em-
ployed both for risk-adjusted preoperative evaluation, and to establish accu-
rate matching criteria for comparative studies.Intra-operative DynaCT improves technical success of endovascular repair
of abdominal aortic aneurysms
Lukla Biasi, Tahir Ali, Lakshmi Arumagum Ratnam, Rob Morgan, Ian Loftus,
Matt Thompson
Objectives: To evaluate feasibility, technical success, and the need for re-
intervention in the early perioperative period, following the introduction of
intraoperative DynaCT (DynaCT, Siemens AG, Berlin, Germany) in patients
undergoing infrarenal endovascular aneurysm repair (EVAR). DynaCT
involves the generation of computed tomography (CT)-like images from
‘‘on table’’ rotational angiographic acquisition.
Methods: A prospectively maintained database of 312 patients undergoing
EVAR (September 2001 - February 2007) was interrogated to determine inci-
dence of early reintervention following satisfactory appearances of unipla-
nar completion angiography (control group). Following the introduction of
DynaCT (DynaCT group e 80 patients), clinical and radiologic outcomes were
prospectively evaluated (September 2007 - May 2008). Both groups under-
went pre-discharge computed tomographic angiography (CTA) and color-flow
duplex scan. Comparative analysis of procedural data, hospital-stay,
mortality, and early reintervention between the two groups was undertaken.
Results: In the control group, 14 (4.5%) patients required reintervention
procedures within 30 days of EVAR (10 endovascular, 7 surgical). Six patients
had type 1 endoleaks and 8 presented with acute limb ischemia. Review of
this cohort suggested that the majority of complications (86%) may have
been immediately identifiable with improved intra-operative quality
control. In the DynaCT group, DynaCT was feasible in 81.3% (n = 65/80) of
patients and resulted in the detection of five clinically significant anomalies
(6.25%, n = 5/80). These technical problems were not identified at comple-
tion angiography but were corrected after DynaCT (2 type 1 endoleaks, 1
type 3 endoleak, 1 limb compression, and 1 graft thrombosis). Standard
pre-discharge imaging did not identify any further graft-related complica-
tions in the DynaCT group. Introduction of DynaCT resulted in a reduced
need for early reintervention (0/80 vs 14/312, P = .05).
Conclusion: Most graft-related complications that mandate early reinter-
vention following EVAR are due to remediable technical problems which
are not identified by uniplanar completion angiography alone. DynaCT is
a feasible intra-operative adjunct to completion angiography, which
improves intra-operative quality control during endovascular repair of
abdominal aortic aneurysms.Transposition of radial artery for reduction of excessive high-flow in
autogenous brachial-cephalic and brachial-basilic upper arm accesses
for hemodialysis
Pierre Bourquelot, Julien Gaudric, Luc Turmel-Rodrigues, Gilbert Franco,
Olivier Van Laere, Alain Raynaud
Objective: All surgical methods published to date for the reduction of
excessive high-flow in native elbow fistulas for dialysis have limitations.
We report a new surgical approach to flow reduction by transposition of
the radial artery to the elbow level.
Methods: From 1992 to 2008, 47 consecutive patients (22 women) with
brachial artery to elbow vein autogenous fistula underwent flow reduction
via replacement of brachial artery by transposed distal radial artery inflow.
Fistulas were side-to-end either brachial-cephalic (19) or brachial-basilic
(28). The indications were hand ischemia (4), cardiac failure (13), concerns
about future cardiac dysfunction (23), and chronic venous hypertension
resulting in aneurysmal degeneration of the vein (7). Mean patient age
was 44 years, 11% were diabetic, 17% were smokers, and mean BMI was
22. Mean fistula age before flow reduction was 2.5 years.Results: Technical success was 91% (43 of 47). The mean flow rate dropped
by 66%  14%. Clinical success in symptomatic patients was 75% (18 of 24).
The fistula eventually had to be ligated in three cases of cardiac failure
because of insufficient clinical improvement. All four patients with hand
ischemia were cured, with no recurrence during follow-up. Primary patency
rates at one and three years were 61%  7% and 40%  8%. Secondary
patency rates at one and three years were 89%  5% and 70%  8%.
Conclusion: Transposition of the radial artery, a safe and effective tech-
nique, might now be considered in the surgical armamentarium of flow
reduction techniques.Clinical autologous in vitro endothelialization of infrainguinal ePTFE
grafts: Long-term experience in 318 patients
Manfred Deutsch, Johann Meinhart, Peter Zilla, Norbert Howanietz, Michael
Gorlitzer, Alexander Froeschl, Andreas Stuempflen, Deon Bezuidenhout,
Martin Grabenwoeger
Objective: Based on a previous randomized study showing significantly
superior patency rates for in vitro endothelialized expanded polytetrafluor-
oethylene (ePTFE) grafts we investigated whether it was feasible for a non-
tertiary institution to offer autologous in vitro endothelialization to all
elective infrainguinal bypass patients who had no suitable saphenous vein
available.
Methods: Over a period of 15 years, 310 out of 318 consecutive nonacute
patients (age 64.7  8.6) received 341 endothelialized ePTFE grafts (308 fe-
moropopliteal: 153 above knee [AK] and 155 below knee [BK] and 33 femor-
odistal). Autologous endothelial cells were harvested from short segments
(3.9  1.1 cm) of subcutaneous veins (80% cephalic, 11% basilic, 2% external
jugular, and 7% saphenous) and grown to mass cultures within 18.9  4.5
days before being confluently lined onto fibrin glue-coated ePTFE grafts.
The graft diameter was 6 mm (64%) or 7 mm (36%). The overall procedure-
related delay for graft implantation was 27.6 þ 7.8 days. Growth failure pre-
vented 2.5% of patients from receiving an endothelialized graft. The mean
observation period was 9.6 years. Primary patencies were obtained from
Kaplan-Meier survivorship functions. Explants for morphological analysis
were obtained from eight patients.
Results: The overall primary patency rate of femoropopliteal grafts was
69% at 5 years (68% [AK] vs 71% [BK]) and 61% at 10 years (59% [AK] vs
64% [BK]). Primary patency of 7 mm vs 6 mm grafts was 78%/62% at 5 years
and 71%/55% at 10 years. The difference between the two groups was
statistically significant (log rank test P = .023; Breslow test P = .017). Stage
I vs II/III patients showed 5-year patencies of 67% vs 73% (N.S.) and 10-year
patencies of 61%% vs 53% (N.S.). The primary patency of femorodistal
grafts was 52% at 5 years and 36% at 10 years. The limb salvage rate
was 94% (fempop) vs 86% (femdistal) at 5 years and 89% vs 71% at 10 years.
All retrieved samples showed the presence of an endothelium after 38.9 
17.8 months.
Conclusion: Autologous in vitro endothelialization was shown to be a feasible
routine procedure at a nontertiary hospital. Explants confirmed the presence
of an endothelium years after implantation while the primary patency in
the particularly challenging subgroup of patients without a suitable saphenous
vein resembles that of vein grafts.Changing demographics in patients with vascular disease
Christopher J. Kwolek, G. Patrick Clagett
The United States population with vascular disease has changed dramatically
during the past 2 decades, with large increases in the proportion of Hispanic,
African American, and other minority patients. Not only has the number of
these patients increased, but the types and distribution of vascular disease
in minority populations is also different from that encountered in non-
Hispanic whites. Although genetic makeup accounts for some of these differ-
ences, access to vascular care is also an important determinant, with many
minority patients presenting late in the course of the disease process. These
factors create significant challenges for the vascular specialists caring for
these patients. The vascular surgery workforce is composed of >90% white
men and does not currently represent the changes in the population of
patients with vascular disease. In addition, women with vascular disease
comprise up to 50% of many vascular surgery practices. In many parts of
the country, Hispanics and African Americans outnumber non-Hispanic
whites with vascular disease. Yet, women and minority physicians are still
significantly under-represented in the field of vascular surgery. This year’s
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meeting addressed the disconnect between the vascular surgery workforce
and the patients whom we serve. This article reviews the projected demo-
graphic changes in the population of the United States, which supports the
need for training a vascular surgery workforce that is more diverse. This
article also reviews the current status of minority and female representation
in medical schools, surgical training programs, and vascular surgery
programs in the United States.Tips and tricks for avoiding access problems when using large sheath
endografts
Brian G. Peterson, Jon S. Matsumura
Despite the availability of a variety of devices and a plethora of device modi-
fications, thoracic endovascular aortic repair (TEVAR) and endovascular
abdominal aortic aneurysm repair (EVAR) still involve the use of large-profile
delivery systems. Inherent in the use of these large devices in the vascular
patient are problems with remote arterial access.
In the European Collaborators on Stent-graft Techniques for Aortic Aneu-
rysm Repair (EUROSTAR) registry of patients undergoing EVAR, limitations in
arterial access was one of the most common reasons for conversion to anopen procedure, and access complications were seen in 13% of patients.
Similarly, in the multicenter TAG thoracic endoprosthesis (W. L. Gore and As-
soc, Flagstaff, Ariz) trial and in an international survey of physicians per-
forming thoracic aortic stent graft procedures, conduits were needed
because of access-related issues in 15% of patients.
More recently, two United States Food and Drug Administrationeapproved
devices for the treatment of thoracic aortic aneurysms also encountered
remote arterial access limitations. In the Zenith TX2 (William Cook Europe,
ApS, Bjaeverskov, Denmark) trial, conduits were used in 9.4% of patients
during TEVAR, and in the Evaluation of the Medtronic Vascular Talent
Thoracic Stent Graft System for the Treatment of Thoracic Aortic Aneurysms
(VALOR) trial (Medtronic Vascular; Santa Rosa, Calif), iliac conduits were
used in 21.1% of patients. In this latter study, despite excellent technical
success, vascular complications occurred in 21% of patients, accounting for
a large portion of the major adverse events reported. So despite continued
device evolution, remote arterial access remains a significant obstacle.
The aim of this report is to discuss some of the advantages and disadvan-
tages of the options currently available for addressing difficult access issues
in the setting of TEVAR and EVAR, and to describe an approach that may be
successfully used when faced with unfavorable iliac artery anatomy Z
placement of an endovascular conduit, followed by controlled iliac artery
rupture, allowing safe passage of the delivery systems.
